For research use only. Not for therapeutic Use.
Cefminox Sodium Heptahydrate(Cat No.:R055784)is a second-generation cephamycin antibiotic with strong antibacterial activity, particularly effective against Gram-negative and certain Gram-positive bacteria. It works by inhibiting cell wall synthesis, leading to bacterial cell death. This sodium heptahydrate form enhances water solubility, making it suitable for intravenous or intramuscular administration in treating infections like peritonitis, urinary tract infections, and respiratory infections. Cefminox Sodium Heptahydrate is valued in clinical settings for its stability against β-lactamase enzymes, which makes it a reliable option in combating resistant bacterial strains in serious infections.
Catalog Number | R055784 |
CAS Number | 75498-96-3 |
Synonyms | (6R,7S)-7-[[2-[[(2S)-2-Amino-2-carboxyethyl]thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium Salt Heptahydrate; Cefminox Sodium Salt Heptahydrate; Meicelin Hep |
Molecular Formula | C₁₆H₃₄N₇NaO₁₄S₃ |
Purity | ≥95% |
Target | Vitamin D Related/Nuclear Receptor |
Storage | -20°C |
IUPAC Name | sodium;(6R,7S)-7-[[2-[(2S)-2-amino-2-carboxyethyl]sulfanylacetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
InChI | InChI=1S/C16H21N7O7S3.Na/c1-22-15(19-20-21-22)33-4-7-3-32-14-16(30-2,13(29)23(14)10(7)12(27)28)18-9(24)6-31-5-8(17)11(25)26;/h8,14H,3-6,17H2,1-2H3,(H,18,24)(H,25,26)(H,27,28);/q;+1/p-1/t8-,14-,16+;/m1./s1 |
InChIKey | SBIDXLKJYJVQOE-YNJMIPHHSA-M |
SMILES | CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSC[C@H](C(=O)O)N)OC)SC2)C(=O)[O-].[Na+] |